Table 1 Study eligibility criteria

Inclusion criteria

 Age > 18 years

 Angiographically confirmed significant FP stenosis or occlusion by atherosclerosis

 Successful FP intervention (residual stenosis < 30% after EVT)

 Without significant residual inflow disease; intact iliac artery inflow (with or without intervention of iliac or below knee arteries)

 Patent outflow status; at least one arterial runoff in BTK

 All kind of FP interventions including POBA, stent, DCB, DES for TASC A ~ D

Exclusion criteria

 At risk of hemorrhage, bleeding tendency, or thrombophilia

 Acute limb ischemia / inflammatory arterial disease

 Contraindication or allergic to ASA, clopidogrel, Anplone

 Medication of warfarin

 Pregnancy, hepatic dysfunction, thrombocytopenia

 Previous FP bypass surgery or intervention

 Impossible to stop clopidogrel before EVT

 Unable to give informed consent.